AdMeTech

www.admetech.org

AdMeTech Foundation develops strategic partnerships with academia, advocacy, industry, and government to facilitate development and implementation of accurate, affordable, accessible diagnostic tools for improved early detection and treatment of prostate cancer. Specific objectives include:

• Development and implementation of effective strategy for technological innovation and related research
• Education of medical community and general public.

Imaging is the Solution:
Advanced diagnostic technologies will make a direct and profound impact on quality of care, quality of life, and health care costs, including:

• Saving men's lives
• Identifying men requiring preventive measures
• Improving early detection, and staging, of cancer which is critical for cure
• Eliminating unnecessary treatment ‐with all the related complications and costs ‐ by recognizing non‐aggressive prostate cancer
• Enhancing patient monitoring before, during, and after treatment
• Avoiding unnecessary biopsies
• Allowing for least invasive and most effective treatment:
• To be performed in outpatient clinics
• With minimal complications, discomfort and expense
• Reducing health care costs by at least $5 billion per year.

  U.S. Congress Supports AdMeTech’s Initiatives
  AdMeTech has been successfully working with members of the U.S. Congress to develop legislative initiatives calling upon the federal government to put forth the resources necessary to advance prostate diagnostics, including:

• U.S. Senate S. 1734 The PRIME (Prostate Research Imaging & Men's Education) Act;
• U.S. House of Representatives H.R. 3563 The PRIME (Prostate Research Imaging & Men's Education) Act; and
• U.S. House Resolution 353 states that it is the sense of the House of Representatives that Congress and the Executive Branch should recognize the successful use of advanced imaging technologies in the fight against breast cancer and provide additional support for the research and development of technologies for prostate cancer detection and treatment comparable to state-of-the-art mammograms.

Research Projects Planned for 2008-2010

Overall Objectives:

1) To establish an International Prostate MRI Working Group that will accomplish the following goals:

1. Expedite testing of MRI/MRS, currently considered the most promising clinical imaging technology for prostate cancer, for diagnosis and assessment of treatment and
2. Develop near- and long-term research strategy for facilitated advancement of MRI/MRS. This will include development of technical specifications, standards and quality control for clinical testing.

2) To continue expansion of a multi-disciplinary ongoing consortium/Brain Trust on Molecular Imaging of Prostate Cancer for strategic planning to stimulate novel ideas and to expedite fundamental discovery, feasibility studies and technologic innovation.

Keystone Symposia Multiple Sclerosis (A8)

Sponsored by the National Multiple Sclerosis Society
Organizers: James L. Salzer, Anne H. Cross and John Fleming
January 21 - 26, 2009 • Hilton Santa Fe/Historic Plaza • Santa Fe, New Mexico
www.keynotesymposia.org

Despite important recent progress, the etiology of Multiple Sclerosis (MS) remains unknown and important therapeutic needs are unmet. This conference will discuss advances in basic pathogenetic mechanisms and emergent therapies for MS. Emphasis will be on the immunopathogenesis of MS, including mechanisms of lymphocyte activation and trafficking across the blood brain barrier, on sources of axonal pathology, and genetic risk factors. New imaging methods and therapeutic strategies that target the immune system and promote remyelination will be discussed. An important challenge in MS research is to integrate emerging insights in the basic mechanisms of myelination, autoimmune demyelination, and neurodegeneration with translational science. The goal of this meeting is to provide a broad spectrum of MS researchers with a forum to discuss recent advances, and to foster cross-disciplinary interactions and collaborations.

MAGNETIC RESONANCE POSTDOCTORAL POSITION

The Department of Radiology and Biomedical Imaging at the University of California, San Francisco, has an immediate opening for a postdoctoral position. The position is with the Department’s Center for Imaging of Neurodegenerative Diseases (CIND), located at the Veterans Affairs Medical Center in San Francisco.

The focus of the position will be on the development of new magnetic resonance spectroscopic acquisition methods for detection of brain metabolites at 4 Tesla and the application and development of spectral analysis techniques. The successful applicant will be expected to further advance methods for detection of J-coupled metabolites at high magnetic fields and is expected to be familiar with corresponding RF pulse design and spectroscopic analysis methods suitable for clinical research. The candidate would also collaborate on several ongoing clinical studies of epilepsy, normal aging, dementias, substance abuse, and other neurodegenerative diseases. Additional information about the CIND is available at the CIND website: http://www.cind.research.va.gov/

The candidate should have a Ph.D. in physics, physical chemistry, engineering or equivalent fields. The ideal candidate has a solid background in NMR physics, especially spectroscopy, signal detection and processing theory, and demonstrated hands-on experience in pulse sequence development, preferably within the Siemens IDEA programming environment. Experience in other computer languages, including C++, Matlab and IDL, is desirable.

Interested applicants should email a letter of research interests and a CV to:

Dr. Gerald Matson, Ph.D. gerald.matson@ucsf.edu

2009 CMSC

TEAMWORK, TRENDS, AND TECHNOLOGY: NEW SOLUTIONS IN MULTIPLE SCLEROSIS

Online: www.mscare.org
Email: info@mscare.org
Postal Mail: Consortium of MS Centers
Attn: Whitaker Research Track 2009
359 Main Street, Suite A Hackensack, NJ 07601
(201) 487-1050 x 104
Deadline: (extended) Jan 26, 2009

Dr. John N. Whitaker was a world famous researcher in multiple sclerosis. Not only did Dr. Whitaker engage in research himself, he encouraged budding scientists to enter the field and develop their skills and talents in this important work. The CMSC is proud to honor Dr. Whitaker’s memory by presenting the Whitaker Research Track each year as part of its annual meeting. Starting in 2004, the Whitaker Track, chaired by Dr. Michael Racke, was expanded to include the work of young scientists working in the field of MS. Students, post-doctoral fellows, and young scientists are encouraged to submit abstracts of their work for presentation during the Whitaker Track. A panel headed by Dr. Racke will judge the presentations and will award the Whitaker Prize for MS Research. A $5,000 grant will be given to the winner to support his or her continued work in the field of MS.

Young scientists whose abstracts are chosen will be provided with transportation, hotel support and free registration from the CMSC and will have the opportunity to interact with clinicians and scientists who specialize in MS.

The Whitaker Track will begin with an opening lecture for all attendees presented by Dr. Kottil Rammohan from 8-8:45 am on Friday. The program will continue with abstract platform session and invited speakers from 9 am - 4:00 pm.

ICMRM 10

The 10th International Conference on Magnetic Resonance Microscopy

West Yellowstone, Montana, USA
August 30 -Sep 4, 2009

ICMRM
The objectives of the ICMRM are to communicate recent developments in high-resolution, spatially resolved magnetic resonance methods and applications. Meeting strength stems from the eclectic background of participants and a diverse venue that has traditionally focused on non-clinical applications in science and engineering areas. The 1st ICMRM was held in 1991 in Heidelberg and was originally known as the "Heidelberg Conference“. It is the biannual conference of the Division of Spatially Resolved Magnetic Resonance of the AMPERE Society.

CMMR
The 9th Colloquium on Mobile NMR (CMMR9) will be part of the conference. The objectives of the CMMR are to communicate the development and applications of Mobile Magnetic Resonance, and to promote hands-on experience of mobile NMR equipment.

ICMRM Book
Following the 9th ICMRM, a book including a number of the significant advances in the field of spatially resolved magnetic resonance was prepared. This book is available through Wiley-VCH


For updates or more information: visit www.icmrm10.montana.edu or email icmrm10@montana.edu

2nd Frontiers of Biomedical Imaging Science conference

Vanderbilt University June 3-6, 2009

We invite you to the second Frontiers of Biomedical Imaging Science conference, an international meeting highlighting the most recent advances and the future directions in biomedical imaging. This year's meeting promises an extraordinary opportunity for connecting with other imaging scientists and learning about innovations in the field.

Trainees are especially encouraged to attend - we are offering subsidized registration and housing rates, as well as the opportunity to present a poster. All posters will be on display during the entire meeting, including a dedicated poster session, and four outstanding posters will be highlighted during a Young Investigators' Symposium. Instructions for abstract submission will be available by January 1. The submission deadline is March 1, and announcements of the posters chosen for the meeting will be made after April 1.

WHEN
Wednesday, June 3, 2009 8:15 AM -
Friday, June 5, 2009 1:00 PM

WHERE
Vanderbilt University Student Life Center
310 25th Avenue South
Nashville, TN 37240
USA

Second joint meeting of ACTRIMS and CMSC

May 27 - 30, 2009
Hyatt Regency
Atlanta, Georgia

Call for Abstracts
Researchers with an interest in multiple sclerosis are invited to submit a competitive abstract for a poster or platform presentation for ACTRIMS 2009. Review the submission guidelines and submit an abstract via www.actrims.org.

Pardon our progress!
We’re updating our website: www.actrims.org. Click here to view the preliminary 2009 program agenda on “Environmental Risk Factors in Multiple Sclerosis.”

Abstracts may be submitted online through January 26, 2009. Up to 7 abstracts will be selected for platform presentations and as many as 100 abstracts will be selected as poster presentations.

Abstract submissions are welcome in a variety of research categories covering basic and clinical issues in MS:

* Disease Modifying Therapy
* Epidemiology/Genetics
* Experimental Disease Models
* Imaging
* Neuroimmunology
* Neuropsychology/Neuropsychiatry
* Pathology
* Rehabilitation and Quality of Life
* Surrogate Markers (non-MRI)
* Symptom Management

Young Researcher Awards
To encourage emerging clinicians, clinical researchers, and basic scientists to continue their work in the field of multiple sclerosis research, the ACTRIMS Steering Committee will offer up to two $1,500 prizes for best platform or best poster presented by young researchers. The presenting authors must certify that they are 35 years old or younger, i.e., born on or after January 1, 1974. A limited number of travel awards will also be available to young researchers who are presenting.


ACTRIMS meetings are organized by the National Multiple Sclerosis Society in collaboration with the MS Society of Canada.


From:
Research & Clinical Programs Department
National Multiple Sclerosis Society
733 Third Avenue
New York, NY 10017 USA
212-476-0469